newsfilter
← Latest News
Business Wire·

TYME Technologies, Inc. Announces Additional Encouraging Preclinical Data on the Effect of TYME-19 in SARS CoV-2 Infections

-- TYME-19 demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells, a model frequently used for drug screening for antiviral efficacy -- -- Completed toxicity studies with TYME-19 that are expected to enable an Investigatio